In Vitro and In Vivo Vascular Selectivity of Lercanidipine and Its Enantiomers
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 29 (Sup 1) , S25-S32
- https://doi.org/10.1097/00005344-199729001-00005
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivityCardiovascular Drugs and Therapy, 1992
- Tissue‐specific expression of high‐voltage‐activated dihydropyridine‐sensitive L‐type calcium channelsEuropean Journal of Biochemistry, 1991
- New generation dihydropyridine calcium entry blockers: In search of greater selectivity for one tissue subtypeGeneral Pharmacology: The Vascular System, 1989
- Second generation calcium channel blockers in the treatment of chronic heart failure: Are they any better than their predecessors?*Journal of the American College of Cardiology, 1989
- ???Second Generation??? Dihydropyridine Calcium AntagonistsDrugs, 1987
- Calcium channel antagonists, part I: Fundamental properties: Mechanisms. classification, sites of actionCardiovascular Drugs and Therapy, 1987
- Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failureThe American Journal of Cardiology, 1985
- Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function.Circulation, 1982
- Nifedipine and left ventricular function in beta-blocked patients.Heart, 1981
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977